Fitzpatrick attorneys defeat motion to stay discovery and bifurcate trial on willfull infringement
Fitzpatrick, on behalf of its client Novartis, recently prevailed in defeating Apotex's motion to stay discovery and bifurcate trial on the issue of willfull infringement. The case involves Novartis' Miacalcin® calcitonin nasal spray product for osteoporosis. Fitzpatrick's litigation team was led by Nicholas N. Kallas and Diego Scambia.
View Attachment (PDF)
Back to Representative Cases
- Related Practice Area